Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil for LUTS/BPH Prior to Prostatectomy
NCT02252367Phase 4Completed
- Sponsor
- Università degli Studi di Firenze
- Start
- Dec 2015
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tadalafil in benign prostatic hyperplasia (BPH), lower urinary tract symptoms (LUTS), sponsored by Università degli Studi di Firenze. Started Dec 2015; status: completed.
02
Drugs
tadalafil
03
Conditions
benign prostatic hyperplasia (BPH)lower urinary tract symptoms (LUTS)
Beyond the preview
Go deeper on NCT02252367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02252367.